Clinical Trial Update: A Phase 3 Clinical Study of KHK 4827 [Phase 3]

View source ↗

Summary

Phase 3 trial update for KHK 4827 across psoriasis-related conditions; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmoplantar Psoriasis
• Psoriasis Vulgaris
• Psoriatic Arthritis
• Psoriatic Erythroderma
• Pustular Psoriasis

Drugs mentioned

• KHK 4827

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Psoriasis Vulgaris, Psoriatic Arthritis | Phase 3 | Status: COMPLETED